Stella buys Field Trip ketamine assets | Crain's Chicago Business
Walgreens earnings disappoint, Augmedic's big venture-capital haul and more in today's Health Pulse.
Stay updated with breaking news from Mujeeb Jafferi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Walgreens earnings disappoint, Augmedic's big venture-capital haul and more in today's Health Pulse.
Specialty biotech company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has filed a pre-submission facility correspondence in advance of its Abbreviated New Drug Application (ANDA) for its novel racemic ketamine KETARX to the FDA.
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 12, 2023 AND MANAGEMENT INFORMATION CIRCULAR JUNE 13, 2023 ... | June 20, 2023
Post-quarter end, launched a refreshed version of the Company’s award-winning app for psychedelic guidance, renamed ‘Field Trip’, to include a number of...
Transaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next...